Caricamento...
Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is the most frequent type of lung cancer accounting up to 80-85% of all lung cancer cases. Gemcitabine (Gem), a pyrimidine nucleoside antimetabolite, is widely used chemotherapy offering several months survival benefit in patients with NSCLC. The emergence of Gem r...
Salvato in:
| Pubblicato in: | Eur J Pharmacol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7669739/ https://ncbi.nlm.nih.gov/pubmed/32805254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2020.173486 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|